32 Stocks Moving in Thursday's Pre-Market Session

Gainers

• BioPharmX Corporation BPMX shares rose 56.4% to $0.73 in pre-market trading after the company reported approval of merger with Timber Pharma by shareholders.
• Immunic, Inc. IMUX rose 33.5% to $13.59 in pre-market trading after the company reported it received first regulatory approval from German Health Authority BfArM to initiated a Phase 2 clinical trial of its selective oral DHODH inhibitor, IMU-838, in COVID-19 patients.
• Applied DNA Sciences, Inc. APDN rose 31.6% to $11.70 in pre-market trading after the company received FDA emergency use authorization for COVID-19 diagnostic assay kit.
• AIM ImmunoTech Inc. rose 29% to $3.02 in pre-market trading after the company reported Q1 results and announced the FDA authorization for first human ampligen trial in coronavirus patients with cancer.
• Co-Diagnostics, Inc. CODX rose 24.5% to $29.19 in pre-market trading after surging 38% on Wednesday.
• Cellectis S.A. CLLS shares rose 18.7% to $16.25 in pre-market trading after declining around 9% on Wednesday.
• eMagin Corporation EMAN rose 14.7% to $0.6310 in pre-market trading after dropping over 21% on Wednesday.
• Revolve Group, Inc. RVLV shares rose 14% to $17.05 in pre-market trading after the company reported better-than-expected Q1 results.
• MEI Pharma, Inc. MEIP rose 13.4% to $3.21 in pre-market trading. MEI Pharma and Kyowa Kirin highlighted updated clinical data from Phase 1b study of ME-401 on intermittent schedule in patients with follicular lymphoma and other B-cell malignancies for the ASCO.
• Banco Santander (Brasil) S.A. BSBR rose 12.5% to $4.40 in pre-market trading.
• Arcadia Biosciences, Inc.. RKDA rose 11.9% to $5.38 in pre-market trading after reporting Q1 results.
• Verona Pharma plc VRNA rose 11.4% to $4.20 in pre-market trading after the company announced FDA response to end-of-Phase 2 briefing package for ensifentrine in COPD and outlined Phase 3 ENHANCE clinical program.
• Futu Holdings Limited FUTU rose 11.6% to $13.70 in pre-market trading after reporting Q1 results.
• Riot Blockchain, Inc. RIOT rose 11.1% to $2.10 in pre-market trading after surging 18% on Wednesday.
• Genocea Biosciences, Inc. GNCA rose 11% to $2.94 in pre-market trading. Genocea highlighted that it will present long-term follow-up data from GEN-009 vaccine at the ASCO.
• SM Energy Company SM rose 9.4% to $3.37 in pre-market trading after falling 12% on Wednesday.
• The GEO Group, Inc. GEO rose 9% to $11.55 in pre-market trading after declining over 5% on Wednesday.
• Upwork Inc. UPWK rose 7.5% to $14.60 in pre-market trading after surging over 10% on Wednesday.
• Cisco Systems, Inc. CSCO rose 3% to $43.21 in pre-market trading after the company reported better-than-expected earnings and sales for its third quarter and issued strong earnings outlook for the current quarter.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Intelsat S.A. I fell 36% to $0.5001 in pre-market trading after the company filed voluntary Chapter 11 petitions in the U.S. Bankruptcy Court for the Eastern District of Virginia.
• Comstock Resources, Inc. CRK fell 26% to $4.81 in pre-market trading after the company reported the commencement of a 40 million share common stock offering.
• MacroGenics, Inc. MGNX shares fell 18.9% to $21.49 in pre-market trading. MacroGenics will present preliminary clinical results from MGD013 and MGC018 at the ASCO.
• Remark Holdings, Inc. MARK shares fell 18.5% to $1.42 in pre-market trading. Remark Holdings will review financial results for the fiscal year on Thursday, May 28, 2020.
• ToughBuilt Industries, Inc. TBLT fell 11.4% to $1.17 in pre-market trading after dropping over 5% on Wednesday.
• Party City Holdco Inc.PRTY fell 10.3% to $0.4230 in pre-market trading after dropping 10% on Wednesday.
• J. C. Penney Company, Inc. JCP fell 10.2% to $0.20 in pre-market trading after gaining 12% on Wednesday.
• Energy Focus, Inc. EFOI shares fell 9.8% to $0.4907 in pre-market trading after jumping 38% on Wednesday.
• HighPoint Resources Corporation HPR fell 8.8% to $0.24 in pre-market trading after dropping 6% on Wednesday.
• Biocept, Inc. BIOC fell 8.7% to $0.4006 in pre-market trading after reporting Q1 results.
• National Health Investors, Inc. NHI fell 7.8% to $44.00 in pre-market trading after dropping over 5% on Wednesday.
• Jack in the Box Inc. JACK fell 3.7% to $61.37 in pre-market trading after the company reported downbeat earnings for its second quarter
• SmileDirectClub Inc SDC fell 3.3% to $7.47 in pre-market trading after the company reported a wider-than-expected loss for its first quarter. The company’s unique aligner shipments rose 12% to 122,751 during the quarter.